<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">Ribavirin has been demonstrated to decrease human metapneumovirus replication in the lungs in a mouse model [
 <xref ref-type="bibr" rid="CR98">98</xref>], and intravenous ribavirin has been effective in the treatment of several lung transplant recipients with metapneumovirus infection [
 <xref ref-type="bibr" rid="CR99">99</xref>].
</p>
